ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1121

Breach of B Cell Anergy in New Zealand Black Congenic Mice

Kieran Manion1,2, Yuriy Baglaenko1,2, Nan-Hua Chang3 and Joan Wither3, 1Immunology, University of Toronto, Toronto, ON, Canada, 2Genetics and Development, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 3University Health Network, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: anti-dsDNA, autoantibodies, B cell tolerance, flow cytometry and mouse model

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Anti-DNA B cells are a primary cause of pathology in individuals with systemic lupus erythematosus (SLE), producing autoantibodies that deposit in diverse tissues and cause extensive inflammatory damage. Congenic mice generated through the introgression of New Zealand Black (NZB) chromosome 1 (C1) susceptibility loci onto the non-autoimmune C57BL/6 (B6) strain are an effective way of modelling lupus and parsing its pathogenesis. Our laboratory has previously provided evidence that a B cell defect instrumental in autoantibody production localizes to the C1d (170.8-181 Mb) region of the NZB C1 and we have further shown that additional T cell and dendritic cell (DC) defects map to the C1b-d (124-181 Mb) locus. Since B cells from both C1d and C1b-d mice with transgenes for hen egg lysozyme (HEL)-specific immunoglobulin and soluble HEL demonstrated a breach of anergy, we hypothesized that the C1d interval alone would be sufficient to breach tolerance to nuclear antigen. Here, we have used a knock-in model of anergy to ssDNA to address this question.

Methods: Genes for the 3H9 heavy chain (IgHa) and Vκ8 light chain were knocked into their proper loci in the C1d and C1b-d congenic strains in order to generate mice with homogeneous, ssDNA-specific B cell repertoires. Female B6, C1d and C1b-d Vκ8/3H9 and wild type mice were aged to 8 months, at which time sera, splenocytes and bone marrow were collected. Serum levels of anti-nuclear autoantibody production were measured by ELISA, while T and B cell activation and localization were assessed using flow cytometry and immunofluorescence microscopy.  

Results: C1d.Vκ8/3H9 mice produce significantly higher levels of anti-ssDNA IgG2aa autoantibodies compared to their B6 counterparts. In line with this increased IgG2aa production, these mice also have a significant increase in the proportion of germinal centre B cells and plasma cells compared to B6 Vκ8/3H9 mice. As anticipated, C1b-d.Vκ8/3H9 mice show an even stronger breach of anergy, with significant increases in anti-ssDNA IgG, IgM and IgG2aa autoantibodies as well as significantly higher proportions of germinal centre B cells than their B6 counterparts. These changes mirror the observed increase in the number of follicular helper and IFNγ-producing T cells, which are thought to provide support for germinal centre B cell development and subsequent autoantibody production. C1d and C1b-d mice also show evidence of defective receptor editing, with significantly lower proportions of B cells with the Igλ1 light chain in the bone marrow compared to B6 counterparts. In agreement with our previous observations of increased survival and peripheral expansion of autoreactive B cells in the HEL model, the proportions of Igλ1+ B cells normalize in the spleen, further supporting the observed breach of anergy.

Conclusion: Our results confirm the presence of a B cell defect to nuclear antigen in the C1d interval and further imply that this defect involves perturbation of both central and germinal centre tolerance.


Disclosure: K. Manion, None; Y. Baglaenko, None; N. H. Chang, None; J. Wither, None.

To cite this abstract in AMA style:

Manion K, Baglaenko Y, Chang NH, Wither J. Breach of B Cell Anergy in New Zealand Black Congenic Mice [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/breach-of-b-cell-anergy-in-new-zealand-black-congenic-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/breach-of-b-cell-anergy-in-new-zealand-black-congenic-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology